Straumann Holding AG

QS51

Company Profile

  • Business description

    Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

  • Contact

    Peter Merian-Weg 12
    Basel4002
    CHE

    T: +41 619651111

    E: [email protected]

    https://www.straumann-group.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2025

    Employees

    11,948

Stocks News & Analysis

stocks

2 ASX shares that benefit from sticky inflation

Inflation is a key risk to shareholders. Here’s why these two ASX shares benefit from higher inflation.
stocks

Our view of Dexus / Scentre deal

Dexus acquires stake in Westfiend Chermside.
stocks

Undervalued ASX retailer benefiting from rebound in spending

Uplift in sales momentum continues.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,923.807.50-0.08%
CAC 408,124.8856.260.70%
DAX 4024,229.9143.420.18%
Dow JONES (US)48,327.79130.26-0.27%
FTSE 1009,751.31102.281.06%
HKSE25,628.88347.91-1.34%
NASDAQ23,079.42115.75-0.50%
Nikkei 22550,168.11668.44-1.31%
NZX 50 Index13,408.141.230.01%
S&P 5006,812.1315.28-0.22%
S&P/ASX 2008,635.008.90-0.10%
SSE Composite Index3,867.9221.42-0.55%

Market Movers